SCIENTIFIC AGENDA
Posters Discussions
Combined modality therapy
Chairs: Nicholas Thatcher, MD, BChir,
PhD, FRCPC and Kathy S. Albain,
MD
Discussants: Daniel Betticher, Laurie
E. Gaspar, MD and Jacek Jassem
Combined
modality therapy
Discussant: Daniel C. Betticher,
MD
Combined
modality therapy
Discussant: Laurie E. Gaspar, MD
Combined
modality therapy
Discussant: Jacek Jassem, MD, PhD
Early detection and prevention
Chairs: Pieter E. Postmus, MD, PhD
and James R. Jett, MD
Discussants: Elisabeth Brambilla,
MD, Robert van Klaveren and Stephen
Lam, MD
New
Technology
Discussant: Elisabeth Brambilla,
MD
Chemoprevention
and Intermediate Biomarkers
Discussant: Stephen Lam, MD
Cell and molecular biology
Chairs: Robert Kratzke, MD and Montserrat
Sanchez-Cespedes, PhD
Discussants: William Pao, David
Sidransky, Paul H. Gumerlock, MD
and Bruce Johnson, MD
Cell
and molecular biology
Discussants:
Bruce E. Johnson, MD, Monserrat
Sanchez-Cespedes, PhD, Paul H. Gumerlock
PhD, Robert Kratzke, MD
NSCLC early disease
Chairs: Bernard Passlick
Discussants: Rodolfo Bordoni, MD,
Frank Griesinger, Rolf Lewensohn,
and Alex Chang
NSCLC
early disease
Discussant: Rodolfo Bordoni, MD
NSCLC
early disease
Discussant: Frank Griesinger
Radiotherapy poster discussion
session
Chairs: Suresh Senan and Choi Eun
Kyung
Discussants: C. le Pechoux, Maria
Werner-Wasik, MD, Kenneth Forster,
Dirk De Ruysscher, MD, PhD
Radiotherapy
pattern of failure: DISCUSSANT:
C. le Pechoux / Radiation pneumonitis
Discussant: Maria Werner-Wasik,
MD
Advances
in radiation treatment planning
Discussant: Kenneth Forster, MD
Palliative
radiation therapy
Discussant: Dirk De Ruysscher, MD,
PhD
Surgery
Chairs: Masahiro Tsuboi and Paul
van Schil
Discussants: Hiromi Wada, MD, David
Harpole, Jr., MD and Peter Goldstraw,
MB, FRCS
Surgery
Discussant: Peter Goldtraw, MB,
FRCS
Surgery
Discussant: David H. Harpole, Jr.,
MD
Surgery
Discussant: Hiromi Wada, MD
Targeted therapies
Chairs: Gerold Bepler, MD, PhD and
Susana Benlloch
Discussants: Gerold Bepler, MD,
Phil Bonomi, MD Karen Kelly, and
Noemi Reguart, MD
Targeted
therapies
Discussant: Gerold Bepler, MD, PhD
Targeted
therapies
Discussant: Noemi Reguart, MD